Overall, our study supports that G-proteins may constitute a key-mechanism regulating MOR inhibition and respiratory depression and can provide new therapeutic targets to reverse or prevent respiratory depression by opioid drugs. The gene discussed is OPRM1; the disease is respiratory depression.